AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15270891
Drug: Topical photodynamic
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical photodynamic therapy with methyl aminolaevulinate
Trial: 31365437
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy adapted for cognitive impairments (CBT‐ABI), 9 sessions
Trial: 27578124
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin E supplementation (1200 IU/d for 12 weeks)
Trial: 18403134
Drug: Atomoxetine (25-100mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (25-100mg daily)
Trial: 10802078
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate patches, 0.1 mg/h
Trial: 8803306
Drug: Leuprorelin acetate
RxNorm normalized name: Leuprorelin acetate
DrugBank: Leuprolide (DB00007)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Leuprorelin acetate depot (LA) 3.75 mg injected subcutaneously every 28 days
Trial: 8803306
Drug: Danazol 800
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 800 mg daily oral dose
Trial: 1320563
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (two puffs qid 2 mg/puff)
Trial: 31053215
Drug: Imagery Rehearsal
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imagery Rehearsal (IR) + Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Trial: 26974539
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of febuxostat 40-mg tablet
Trial: 26974539
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of febuxostat 40-mg tablet
Trial: 26974539
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of febuxostat 80-mg tablet
Trial: 26974539
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of febuxostat 80-mg tablet
Trial: 21546512
Drug: Two-quadrant technique
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-quadrant technique (5 ml inferonasal and 5 ml superotemporal injection of 50:50 mixture of 2% lidocaine and 0.5% bupivacaine with 150 IU hyaluronidase)
Trial: 21546512
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard 5 ml single inferonasal injection of 50:50 mixture of 2% lidocaine and 0.5% bupivacaine with 150 IU hyaluronidase)
Trial: 17034605
Drug: Vaginal cone
RxNorm normalized name: Pinus strobus cone extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal cone therapy
Trial: 17245662
Drug: Treatment resource
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment resource information package (Control)
Trial: 24028643
Drug: Temazepam 7.5
RxNorm normalized name: temazepam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 7.5 mg
Trial: 12826988
Drug: Temazepam 15
RxNorm normalized name: temazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 15 mg
Trial: 9543434
Drug: Monotherapy or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy or combination therapy with ritonavir
Trial: 9543434
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with ritonavir or combination therapy with ritonavir and zidovudine
Trial: 2448358
Drug: terfenadine (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine (120 mg, twice daily for 3 days)
Trial: 29606104
Drug: Ubiquinol and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ubiquinol and/or D-ribose administered for 12 weeks
Trial: 27252841
Drug: Sildenafil 20
RxNorm normalized name: sildenafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 20 mg 3 times a day
Trial: 25527071
Drug: Tenofovir gel
RxNorm normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tenofovir gel provision through family planning services
Trial: 25527071
Drug: Tenofovir gel
RxNorm normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tenofovir gel provision through CAPRISA research clinics
Trial: 17582225
Drug: 1.7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.7 g DHA and 0.6 g EPA (omega3 group) daily for 6 months
Trial: 8994319
Drug: 2 year
RxNorm normalized name: Childrens Panadol 5 - 12 Years
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 year old hepatitis A vaccine
Trial: 8994319
Drug: newly produced
RxNorm normalized name: RECOMBINANT DNA DERIVED B-DOMAIN DELETED PORCINE BLOODCOAGULATION FACTOR VIII ANALOGUE, PRODUCED IN BHK21 CELLS: DES-(753-1418)-BLOOD-COAGULATION FACTOR VIII (PROCOAGULANT COMPONENT) SUS SCROFA, GLYCOSYLATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: newly produced hepatitis A vaccine
Trial: 6230296
Drug: Thymostimulin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymostimulin (1 mg/kg/day for seven days; 1 mg/kg/weekly thereafter)
Trial: 31257435
Drug: Multifaceted intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multifaceted intervention targeting health professionals' and patients' behaviour regarding antibiotic use.
Trial: 23794225
Drug: Denosumab (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (administered once every 6 months for 36 months)
Trial: 22835804
Drug: CHESS+CM (Comprehensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHESS+CM (Comprehensive Health Enhancement Support System + monthly nurse case management via phone)
Trial: 22835804
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (treatment as usual plus asthma information)
Trial: 20427350
Drug: Chemoradiotherapy (CRT),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiotherapy (CRT), cisplatin 40 mg/m² weekly for seven doses plus RT
Trial: 17905018
Drug: L‐hyoscyamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐hyoscyamine 0.5 mg
Trial: 10817552
Drug: IL-1Ra 30
RxNorm normalized name: IL-1RA
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IL-1Ra 30 mg/day
Trial: 10817552
Drug: IL-1Ra 75
RxNorm normalized name: IL-1RA
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IL-1Ra 75 mg/day
Trial: 10817552
Drug: All IL-1Ra
RxNorm normalized name: IL-1RA
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: All IL-1Ra treatment groups combined
Trial: 6228370
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg orally 2 h before exercise
Trial: 6228370
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide 0.216 mg by inhalation 30 min before exercise
Trial: 28743370
Drug: Vibration group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibration group (50Hz, 0.2N or 20g applied on the buccal surface of maxillary canine)
Trial: 23635884
Drug: 0.12% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% chlorhexidine gel (CHX)
Trial: 16989497
Drug: Barnidipine (10-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barnidipine (10-15 mg)
Trial: 15284828
Drug: 200 mg/d,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/d, 3 cycles
Trial: 15284828
Drug: 200 mg/d,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/d, 6 cycles
Trial: 15284828
Drug: 400 mg/d,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/d, 3 cycles
Trial: 10758445
Drug: Epidural clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural clonidine (4 microg kg‐1) combined with epidural morphine (40 microg kg‐1)
Trial: 10758445
Drug: Intravenous clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous clonidine (4 microg kg‐1) combined with epidural morphine (40 microg kg‐1)
Trial: 10758445
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (only epidural morphine)
Trial: 1304175
Drug: .717% fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: .717% fluoride solution
Trial: 1304175
Drug: .04% stannous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: .04% stannous fluoride gel (Gel‐Kam)
Trial: 2413097
Drug: 320 mg
RxNorm normalized name: aspirin 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 320 mg of slow release oxprenolol
Trial: 23079770
Drug: Creatine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine (10 g daily)
Trial: 17593237
Drug: BIAsp30 (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIAsp30 (once daily)
Trial: 17593237
Drug: BIAsp30 (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIAsp30 (twice daily)
Trial: 17611739
Drug: bromocriptine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromocriptine (2.5 mg)
Trial: 12215234
Drug: haloperidol (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol (2.0 mg)
Trial: 9857924
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (0.1 IU x kg(‐1) week(‐1) for 1 week, then 0.25 IU x kg(‐1) week(‐1) for 3 months)
Trial: 7611760
Drug: Tropisetron 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 2.5 mg
Trial: 7611760
Drug: Tropisetron 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 5.0 mg
Trial: 9113121
Drug: Tropisetron 10
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 10 mg
Trial: 7611760
Drug: Tropisetron (optimal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron (optimal dose)
Trial: 356254
Drug: Hexoprenaline (0.20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexoprenaline (0.20 mg/puff)
Trial: 356254
Drug: Terbutaline (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (0.25 mg/puff)
Trial: 16364832
Drug: Lactobacillus helveticus
RxNorm normalized name: Lactobacillus Helveticus
DrugBank: Lactobacillus helveticus (DB14226)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus helveticus LBK‐16H fermented milk (150 mL twice daily for 10 weeks)
Trial: 30999969
Drug: HandScan-guided treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HandScan-guided treatment aimed at 'HandScan remission' (HandScan arm)
Trial: 30999969
Drug: Clinically guided
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically guided treatment aimed at ACR/EULAR 2011 Boolean remission (DAS arm)
Trial: 30999969
Drug: HandScan-guided treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HandScan-guided treatment
Trial: 30999969
Drug: Clinically guided
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically guided treatment
Trial: 24206099
Drug: Atomoxetine (1.0-1.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (1.0-1.4 mg/kg/day)
Trial: 15168891
Drug: Multivitamins plus
RxNorm normalized name: Ferrous Fumarate/Multivitamin Oral Tablet, Chewable [MULTIVITAMINS PLUS IRON CHILDREN'S]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamins plus creatine (amount equal to twice daily creatinine excretion) for four weeks
Trial: 8843295
Drug: Rifabutin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin (300 mg daily for 14 days)
Trial: 8645788
Drug: Rifabutin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin (300 mg daily for 7 or 14 days)
Trial: 2083857
Drug: Solution VI
RxNorm normalized name: Mitomycin 40 mg powder for intravesical solution vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution VI (glucose 80, sodium 30, potassium 20 mmol/l; 177 mOsm/kg)
Trial: 2083857
Drug: Solution II
RxNorm normalized name: Balanced Salt Solution Ophthalmic Solution [OCUSOFT IRRIGATING SOLUTION II]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution II (WHO oral rehydration solution; glucose 111, sodium 90, bicarbonate 30, potassium 20; 308 mOsm/kg)
Trial: 2083857
Drug: Solution IV
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution IV (glucose 111, sodium 60, potassium 20 mmol/l; 260 mOsm/kg)
Trial: 2083857
Drug: Solution III
RxNorm normalized name: antithrombin III Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution III (hypertonic commercial oral rehydration solution; glucose 188, sodium 50, bicarbonate 20, potassium 20 mmol/l; 335 mOsm/kg)
Trial: 2083857
Drug: Solution V
RxNorm normalized name: Flavor Sweet Oral Solution Vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution V (glucose 80, sodium 60, potassium 20 mmol/l; 219 mOsm/kg)
Trial: 2083857
Drug: Solution I
RxNorm normalized name: SOLUTION IN PACKET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution I (standard cleansing solution; sodium 125, potassium 10, bicarbonate 20, sulphate 40, mannitol 80 mmol/l; 275 mOsm/kg)
Trial: 27825893
Drug: Serelaxin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serelaxin (30 µg ⋅ kg‐1 ⋅ d‐1 intravenous infusion for 48 hours)
Trial: 15263050
Drug: Antidepressants and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants and psychotherapy
Trial: 9144118
Drug: Rice syrup
RxNorm normalized name: Rice Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice syrup solid containing ORS in alternation with rice-based, lactose-free infant formula (Group 2)
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using sumatriptan
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using MK‐462
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using 311C90
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using dihydroergotamine
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using nonsteroidal anti‐inflammatory drugs
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using butorphanol
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using metoclopramide
Trial: 8081520
Drug: Acute drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute drug therapy using domperidone
Trial: 8081520
Drug: Prophylactic drug
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic drug therapy using valproate
Trial: 8081520
Drug: Prophylactic drug
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic drug therapy using fluoxetine
Trial: 31948301
Drug: Spinal chiropractic
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal chiropractic manipulative therapy (SCMT)
Trial: 1350796
Drug: beta-blocker +
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-blocker + diuretic
Trial: 27053407
Drug: ACEI +
RxNorm normalized name: Veneno de Abeja Aceite de Vibora
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEI + diuretic
Trial: 27053407
Drug: angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: angiotensin II receptor blocker (ARB) + diuretic
Trial: 18706007
Drug: Combined i.v./i.a.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined i.v./i.a. approach to recanalization (lower dose of i.v. rt-PA approximately 0.6 mg/kg, 60 mg maximum over 40 min, followed by angiography and possible i.a. therapy)
Trial: 18706007
Drug: Standard i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard i.v. rt-PA alone (full dose 0.9 mg/kg, 90 mg maximum over 1 hour)
Trial: 17261975
Drug: Reinstitution or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinstitution or continuation of GH therapy
Trial: 17261975
Drug: Ongoing GH
RxNorm normalized name: FUSION PROTEIN OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG- .BETA.)-(118-145)-PEPTIDE (1-28) WITH HUMAN SOMATOTROPIN (GROWTH HORMONE, GH) (29-219) AND TWO TANDEM COPIES OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG-.BETA.)-(118-145)- PEPTIDE (220-247
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing GH therapy
Trial: 17261975
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of childhood GH replacement therapy without restart in adults
Trial: 12663289
Drug: HIGHNAT-E formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIGHNAT-E formula (20 IU RRR-alpha-tocopheryl acetate/L, 14.5 mg/L)
Trial: 12663289
Drug: LOWNAT-E formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LOWNAT-E formula (10 IU RRR-alpha-tocopheryl acetate/L, 7.3 mg/L)
Trial: 12663289
Drug: SYN-E formula
RxNorm normalized name: Gel-Syn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SYN-E formula (13.5 IU synthetic all-rac-alpha-tocopheryl acetate/L, 13.5 mg/L)
Trial: 10809343
Drug: Oral suspension
RxNorm normalized name: Oral Suspension
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral suspension (200 mg phenytoin)
Trial: 10809343
Drug: Rectal suppository
RxNorm normalized name: Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal suppository (200 mg phenytoin)
Trial: 8841210
Drug: Standard approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard approach (physician‐chosen combinations of intracervical or vaginal dinoprostone every 6 hours, artificial rupture of membranes, and oxytocin infusion)
Trial: 1338088
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg SPFX
Trial: 1338088
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg SPFX
Trial: 29902542
Drug: Topical spray
RxNorm normalized name: Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical spray treatment with 0.005% rhEGF
Trial: 21099198
Drug: Saline spray
RxNorm normalized name: Saline Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline spray (placebo)
Trial: 19446145
Drug: Flurbiprofen axetil
RxNorm normalized name: Flurbiprofen axetil
DrugBank: Flurbiprofen axetil (DB14938)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen axetil 50 mg with tourniquet
Trial: 19446145
Drug: Mixed flurbiprofen
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mixed flurbiprofen axetil 50 mg and propofol
Trial: 2627821
Drug: Cimetidine plus
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine plus antacid (aluminum hydroxide gel)
Trial: 180938
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with carmustine (80 mg/sq m/day for three days) and vincristine sulfate (1.4 mg/sq m on days 1 and 8)
Trial: 180938
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (4,500 rads whole brain plus 1,500 rads to the side of the tumor)
Trial: 23347535
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (FO) 15 mL/day for 6 weeks
Trial: 23347535
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (OO) 15 mL/day for 6 weeks
Trial: 23347535
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (FO) 15 mL/day
Trial: 21872376
Drug: Sulodexide 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulodexide 200 mg/d
Trial: 17409802
Drug: Docetaxel 30
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 30 mg/m2 on days 1, 8, and 15 every 28 days
Trial: 17409802
Drug: Docetaxel weekly
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel weekly (30 mg/m2)